Updated:
Original:

Club drug "Special K" could help people with suicidal depression

Author:

Ketamine, a nightclub drug popularly known as Special K could offer hope to people with severe or suicidal depression.

In a recent study, researchers in Britain gave 28 people with treatment-resistant depression ketamine intravenously over three weeks and found that for many of them, the drug relieved their depression in a matter of hours.

This was true even for people who hadn't responded to other treatments, like talk therapy or antidepressants. Antidepressants can take more than a month to kick in, and don't work for everyone with major depression.

The University of Oxford researchers found that although many people in the study relapsed within a day or two, 29 percent had benefit which lasted at least three weeks and 15 percent took over two months to relapse.

Study author Dr. Rupert McShane says, "We've seen remarkable changes in people who've had severe depression for many years that no other treatment has touched. It's very moving to witness."

The study was published in the Journal of Psychopharmacology.

"Patients often comment that that the flow of their thinking seems suddenly freer. For some, even a brief experience of response helps them to realise that they can get better and this gives hope," McShane says.

Ketamine was developed in the 1960s as an anesthetic and pain reliever and is often used by veterinarians on animals. When taken in high doses as a club drug, ketamine can cause a dissociative effect that puts people in a so-called "K-hole," where they feel detached and experience distortions in how they perceive sights and sounds.

The U.S. government classifies ketamine as a Schedule III drug, meaning they have moderate to low potential for physical and psychological dependence.

CBS News reports the British study is the latest to suggest ketamine may help people with severe clinical depression who aren't helped by antidepressants.

A 2013 study led by researchers at Mount Sinai Medical Center in New York, involving 72 patients with treatment-resistant depression, found almost 64 percent of patients showed improvements in symptoms within 24 hours, and 46 percent had improved symptoms one week later.

In 2012, Yale researchers reported ketamine could treat depression by spurring the release of the neurotransmitter glutamate in the brain, which triggers the growth of synapses, or spaces between nerves that allow information to flow from one nerve cell to another. Chronic stress and depression damages these synapses, the researchers stated at the time, but a single dose of ketamine may rapidly reverse the damage. However, the improvement that's seen within hours may last only a week to 10 days, they warned at the time.

NPR News quotes Christopher Stephens, who had tried lots of medications for his depression without success. He says he felt better after a single dose of ketamine.

"Monday afternoon I felt like a completely different person," he says. "I woke up Tuesday morning and I said, 'Wow, there's stuff I want to do today.' And I woke up Wednesday morning and Thursday morning and I actually wanted to do things.

I wanted to live life."

Next Up

Knuth - Nezhad - side by side

Frey challengers Knuth, Nezhad agree to rank each other 2nd

They're urging supporters to do the same on Nov. 2.

Jerome Horton - Sherburne Co. Jail - CROP

Charges: Man lied to buy gun later used by St. Paul mass shooting suspect

He's accused of making false statements during the purchase of a firearm.

Screen Shot 2021-06-04 at 6.30.24 AM

BCA releases investigative file in Winston Smith's shooting death

The file contains 1,000 pages of documents, hundreds of photos and dozens of audio files.

Slice

Fire at Mpls. pizza joint weeks after opening, owners suspect arson

The owners arrived at work Tuesday to find the building on fire.

vaccine, covid

New COVID charts show hospitalization, death rates based on vaccine status

The unvaccinated are far more likely than the fully vaccinated to become hospitalized or die.

Flickr - Superior National Forest Boundary Waters

White House begins process to ban new mining near BWCAW

The stated goal is to protect the "unique natural wonder" of the BWCAW.

Autumn Merrick, Autumn Rose Merrick

Man charged in shootout, crash that killed 18-year-old on scooter

Autumn Rose Merrick was with a friend near the Holiday gas station.

D Quagon - DOC photo

DOC searching for convicted sex offender who has gone on the run

The recently released man removed his GPS monitoring device.

Related

Doctors: Young people faking symptoms to get drugs

Students at the University of Minnesota tell the Star Tribune that the use of legal and illegal prescription drugs has become common on campus, and a new study says one in four adults fake symptoms to get drugs, news that has some doctors calling for tougher screening tests.